Articles tagged with Inflammasomes
A team of researchers discovered a way to treat severe inflammation from mosquito-borne diseases like Chikungunya and Ross River virus. They developed an NLRP3 inhibitor drug MCC950, which provided significant relief from inflammation and disease in infected mice.
A recent study reveals that microRNA-223 plays a crucial role in regulating intestinal inflammation in inflammatory bowel disease. Synthetic versions of this microRNA can reduce inflammation in mice and may hold promise as a future therapy for IBD patients.
A recent study suggests that a ketogenic diet can protect against gout flares in rats by increasing levels of ketone bodies and inhibiting the NLRP3 inflammasome. This could potentially improve treatment outcomes for humans with the disease.
A study led by Harvard Medical School investigators found that a brain-based immune protein called inflammasome NLRP3 plays a crucial role in regulating sleep. The researchers discovered that the inflammasome recruits a sleep-inducing molecule to trigger somnolence following sleep deprivation and exposure to bacterial toxins.
Scientists at TUM have discovered new mechanisms of action for Imiquimod, a medication used to treat viral skin infections and certain types of skin cancer. The study reveals that Imiquimod activates the NLRP3 inflammasome, which can lead to inflammation and potentially contribute to its efficacy or adverse side effects.
Researchers have discovered that caspase 12 does not act as a dominant-negative regulator of caspase-1 activation and inflammasomes. This finding challenges a stubborn dogma in the field and opens up new avenues for studying caspase 12's role in physiological processes.
Researchers identified a previously unknown pathway that triggers inflammation in human monocytes in response to a single signal, contrasting with the need for two signals in mice. This discovery sheds light on the species difference and refutes classical tenets of inflammasome research.
Researchers have filmed in vivo the process by which an AIDS vaccine candidate recruits immune cells to destroy infected cells. The study, published in Nature Medicine, shows how the vaccine induces the formation of the inflammasome, a complex assembly of proteins that triggers an immune response.
Scientists at the University of Manchester discovered that inflammation in the brain causes and worsens damage after a stroke, contradicting previous theories. The study found that inflammasomes such as NLRP3 are not involved in brain injury caused by stroke, but rather NLRC4 and AIM2 inflammasomes contribute to this damage.
Researchers at Trinity College Dublin have identified a breakthrough molecule, MCC950, that suppresses the NLRP3 inflammasome, a key process in inflammatory diseases. The discovery has significant implications for treating various conditions, including arthritis, multiple sclerosis, and Muckle-Wells syndrome.
Researchers at Yale University found a compound produced by the body during dieting or fasting can block an immune system part involved in several inflammatory disorders. The compound BHB directly inhibits NLRP3, driving inflammation in diseases like autoimmune disorders, type 2 diabetes, and Alzheimer
A component of the plant Glycyrrhiza uralensis has been shown to inhibit the development of metabolic disorders by stopping the activation of NLRP3, a protein involved in disease process. Isoliquiritigenin attenuates high-fat diet-induced obesity, type 2 diabetes and hepatic steatosis in mice.
Rheumatoid arthritis is considered a syndrome rather than a single disease, and blocking inflammasomes may be an effective therapeutic target. Researchers have developed a mouse model that demonstrates the role of inflammasomes in RA and show promise for new treatments.
A team of researchers found that inflammasomes remain active even after cell death, triggering a rapid inflammatory reaction. This discovery offers potential novel approaches for therapies against diseases such as gout, atherosclerosis, and Alzheimer's disease.
A Penn Vet study reveals that Salmonella bacteria evade the immune system by exploiting metabolic pathways, including the citric acid cycle. The research identifies key genes involved in this evasion strategy and suggests that the immune system may recognize bacterial metabolites like citrate to trigger an inflammatory response.
A Yale School of Medicine study found that immune sensor Nlrp3 inflammasome triggers age-related inflammation, leading to loss of function and frailty. Reducing Nlrp3 activation may help delay or prevent chronic diseases.
A University of Michigan study reveals that probiotics can reverse the effect of stress on gut microbiota, reducing inflammation and alleviating symptoms of irritable bowel syndrome. The study also highlights the importance of maintaining a healthy gut microbiome through lifestyle changes.
Researchers have found that blocking the NLRP3 inflammasome can prevent Alzheimer's disease. The study, which involved human and mouse subjects, suggests that suppressing inflammatory reactions may be a promising new approach to therapy.
A major breakthrough in treating geographic atrophy, a form of age-related macular degeneration, has been made by University of Kentucky researchers. The discovery highlights the role of the NLRP3 inflammasome and MyD88 in triggering vision loss due to retinal pigmented epithelial cell death.
A recent study published in the Proceedings of the National Academy of Sciences found that inflammasome amplifies inflammatory responses in the heart, leading to further damage. Pharmacologic inhibition of inflammasome prevents heart enlargement and dysfunction.
Scientists have discovered that pneumolysin triggers an immune response by activating the NLRP3 inflammasome, which provides protection against infection caused by Streptococcus pneumoniae. This breakthrough could lead to more effective vaccines for pneumococcal diseases.
Researchers discovered that specific inflammasome components protect against colitis and cancer in mice. Mice lacking these components developed more severe colitis and larger tumor burdens, highlighting the complex role of inflammasomes in human disease.
Researchers found that alum stimulates clusters of proteins called inflammasomes, which respond to stresses such as infection or injury by releasing immune cell signaling proteins. This discovery provides evidence for the role of Nalp3 inflammasome in alum's adjuvant action.